Gamma-Oryzanol-Rich Fraction from Purple Rice Extract Attenuates Lipopolysaccharide-Stimulated Inflammatory Responses, Migration and VEGFA Production in SW480 Cells via Modulation of TLR4 and NF-κB Pathways

References

• Kobayashi H, Mochizuki H, Sugihara K, Morita T, Kotake K, Teramoto T, Kameoka S, Saito Y, Takahashi K, Hase K, et al. Characteristics of recurrence and surveillance tools after curative resection for colorectal cancer: a multicenter study. Surgery. 2007;141(1):67–75. doi:10.1016/j.surg.2006.07.020
   PubMed Web of Science ®Google Scholar
• van der Bij GJ, Oosterling SJ, Beelen RHJ, Meijer S, Coffey JC, van Egmond M. The perioperative period is an underutilized window of therapeutic opportunity in patients with colorectal cancer. Ann Surg. 2009;249(5):727–34. doi:10.1097/SLA.0b013e3181a3ddbd
   PubMed Web of Science ®Google Scholar
• McMillan DC, Canna K, McArdle CS. The effect of deprivation and the systemic inflammatory response on outcome following curative resection for colorectal cancer. Br J Cancer. 2003;89(4):612–4. doi:10.1038/sj.bjc.6601156
   PubMed Web of Science ®Google Scholar
• Eberhardt JM, Kiran RP, Lavery IC. The impact of anastomotic leak and intra-abdominal abscess on cancer-related outcomes after resection for colorectal cancer: a case control study. Dis Colon Rectum. 2009;52(3):380–6. doi:10.1007/DCR.0b013e31819ad488
   PubMed Web of Science ®Google Scholar
• Greten FR, Grivennikov SI. Inflammation and cancer: Triggers, mechanisms, and consequences. Immunity. 2019;51(1):27–41. doi:10.1016/j.immuni.2019.06.025
   PubMed Web of Science ®Google Scholar
• Rakhesh M, Cate M, Vijay R, Shrikant A, Shanjana A. A TLR4-interacting peptide inhibits lipopolysaccharide-stimulated inflammatory responses, migration and invasion of colon cancer SW480 cells. Oncoimmunology. 2012;1(9):1495–506. doi:10.4161/onci.22089
   PubMed Web of Science ®Google Scholar
• Zou Y, Qin F, Chen J, Meng J, Wei L, Wu C, Zhang Q, Wei D, Chen X, Wu H, et al. sTLR4/MD-2 complex inhibits colorectal cancer in vitro and in vivo by targeting LPS. Oncotarget. 2016;7(32):52032–44.:doi:10.18632/oncotarget.10496
   PubMedGoogle Scholar
• Ianaro A, Tersigni M, D’Acquisto F. New insight in LPS antagonist. Mini Rev Med Chem. 2009;9(3):306–17. doi:10.2174/1389557510909030306
   PubMed Web of Science ®Google Scholar
• Landi S, Moreno V, Gioia-Patricola L, Guino E, Navarro M, de Oca J, Capella G, Canzian F, Bellvitge Colorectal Cancer Study Group. Association of common polymorphisms in inflammatory genes interleukin (IL)6, IL8, tumor necrosis factor alpha, NFKB1, and peroxisome proliferator-activated receptor gamma with colorectal cancer. Cancer Res. 2003;63(13):3560–6.
   PubMed Web of Science ®Google Scholar
• Balkwill F. Tumor necrosis factor or tumor promoting factor? Cytokine Growth Factor Rev. 2002;13(2):135–41. doi:10.1016/S1359-6101(01)00020-X
   PubMed Web of Science ®Google Scholar
• Tang XY, Zhu YQ, Wei B, Wang H. Expression and functional research of TLR4 in human colon carcinoma. Am J Med Sci. 2010;339(4):319–26. doi:10.1097/MAJ.0b013e3181cef1b7
   PubMed Web of Science ®Google Scholar
• Oblak A, Jerala R. Toll-like receptor 4 activation in cancer progression and therapy. Clin Dev Immunol. 2011;2011:609579. doi:10.1155/2011/609579
   PubMedGoogle Scholar
• Fukata M, Chen A, Vamadevan AS, Cohen J, Breglio K, Krishnareddy S, Hsu D, Xu R, Harpaz N, Dannenberg AJ, et al. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology. 2007;133(6):1869–81. doi:10.1053/j.gastro.2007.09.008
   PubMed Web of Science ®Google Scholar
• Wang EL, Qian ZR, Nakasono M, Tanahashi T, Yoshimoto K, Bando Y, Kudo E, Shimada M, Sano T. High expression of Toll-like receptor 4/myeloid differentiation factor 88 signals correlates with poor prognosis in colorectal cancer. Br J Cancer. 2010;102(5):908–15. doi:10.1038/sj.bjc.6605558
   PubMed Web of Science ®Google Scholar
• Killeen SD, Wang JH, Andrews EJ, Redmond HP. Bacterial endotoxin enhances colorectal cancer cell adhesion and invasion through TLR-4 and NF-kappaB-dependent activation of the urokinase plasminogen activator system. Br J Cancer. 2009;100(10):1589–602. doi:10.1038/sj.bjc.6604942
   PubMed Web of Science ®Google Scholar
• Zhu G, Huang Q, Huang Y, Zheng W, Hua J, Yang S, Zhuang J, Wang J, Ye J. Lipopolysaccharide increases the release of VEGF-C that enhances cell motility and promotes lymphangiogenesis and lymphatic metastasis through the TLR4- NF-κB/JNK pathways in colorectal cancer. Oncotarget. 2016;7(45):73711–24. doi:10.18632/oncotarget.12449
   PubMedGoogle Scholar
• Hsu RYC, Chan CHF, Spicer JD, Rousseau MC, Giannias B, Rousseau S, Ferri LE. LPS-induced TLR4 signaling in human colorectal cancer cells increases beta1 integrin-mediated cell adhesion and liver metastasis. Cancer Res. 2011;71(5):1989–98. doi:10.1158/0008-5472.CAN-10-2833
   PubMed Web of Science ®Google Scholar
• Cha JH, Kim WK, Ha AW, Kim MH, Chang MJ. Anti-inflammatory effect of lycopene in SW480 human colorectal cancer cells. Nutr Res Pract. 2017;11(2):90–6. doi:10.4162/nrp.2017.11.2.90
   PubMed Web of Science ®Google Scholar
• Panaro MA, Carofiglio V, Acquafredda A, Cavallo P, Cianciulli A. Anti-inflammatory effects of resveratrol occur via inhibition of lipopolysaccharide-induced NF-κB activation in Caco-2 and SW480 human colon cancer cells. Br J Nutr. 2012;108(9):1623–32. doi:10.1017/S0007114511007227
   PubMed Web of Science ®Google Scholar
• Zhang D, Li Y-h, Mi M, Jiang F-L, Yue Z-g, Sun Y, Fan L, Meng J, Zhang X, Liu L, et al. Modified apple polysaccharides suppress the migration and invasion of colorectal cancer cells induced by lipopolysaccharide. Nutr Res. 2013;33(10):839–48. doi:10.1016/j.nutres.2013.06.004
   PubMed Web of Science ®Google Scholar
• Han M, Song Y, Zhang X. Quercetin suppresses the migration and invasion in human colon cancer Caco-2 cells through regulating toll-like receptor 4/nuclear factor-kappa B pathway. Phcog Mag. 2016;12(46):237–44. doi:10.4103/0973-1296.182154
   Web of Science ®Google Scholar
• Abdel-Aal el SM, Young JC, Rabalski I. Anthocyanin composition in black, blue, pink, purple, and red cereal grains. J Agric Food Chem. 2006;54(13):4696–704. doi:10.1021/jf0606609
   PubMed Web of Science ®Google Scholar
• Boue SM, Daigle KW, Chen MH, Cao H, Heiman ML. Antidiabetic potential of purple and red rice (Oryza sativa L.) bran extracts. J Agric Food Chem. 2016;64(26):5345–53. doi:10.1021/acs.jafc.6b01909
   PubMed Web of Science ®Google Scholar
• Sirithunyalug B, Saenjum C, Charumanee S, Sivamaruthi B, Chaiyasut C, Sirithunyalug J, Tipduangta P. Development of colorectal-targeted dietary supplement tablets containing natural purple rice bran oil as a colorectal chemopreventive. Nutrients. 2018;10(4):444. doi:10.3390/nu10040
   PubMed Web of Science ®Google Scholar
• Jang S, Xu Z. Lipophilic and hydrophilic antioxidants and their antioxidant activities in purple rice bran. J Agric Food Chem. 2009;57(3):858–62. doi:10.1021/jf803113c
   PubMed Web of Science ®Google Scholar
• Pintha K, Yodkeeree S, Pitchakarn P, Limtrakul P. Anti-invasive activity against cancer cells of phytochemicals in red jasmine rice (Oryza sativa L.). Asian Pac J Cancer Prev. 2014;15(11):4601–7. doi:10.7314/apjcp.2014.15.11.4601
   PubMedGoogle Scholar
• Sakai S, Murata T, Tsubosaka Y, Ushio H, Hori M, Ozaki H. γ-Oryzanol reduces adhesion molecule expression in vascular endothelial cells via suppression of nuclear factor-κB activation. J Agric Food Chem. 2012;60(13):3367–72. doi:10.1021/jf2043407
   PubMed Web of Science ®Google Scholar
• Islam MS, Murata T, Fujisawa M, Nagasaka R, Ushio H, Bari AM, Hori M, Ozaki H. Anti-inflammatory effects of phytosteryl ferulates in colitis induced by dextran sulphate sodium in mice. Br J Pharmacol. 2008;154(4):812–24. doi:10.1038/bjp.2008.137
   PubMed Web of Science ®Google Scholar
• Panyathep A, Chewonarin T. Inhibitory effect of a gamma-oryzanol-rich fraction from purple rice extract on lipopolysaccharide-induced metastasis in human colon cancer cells. J Food Biochem. 2020;44(12):e13487. doi:10.1111/jfbc.13487
   PubMed Web of Science ®Google Scholar
• Pijuan J, Barceló C, Moreno DF, Maiques O, Sisó P, Marti RM, Macià A, Panosa A. In vitro cell migration, invasion, and adhesion assays: From cell imaging to data analysis. Front Cell Dev Biol. 2019;7:107. doi:10.3389/fcell.2019.00107
   PubMed Web of Science ®Google Scholar
• Danese S, Mantovani A. Inflammatory bowel disease and intestinal cancer: a paradigm of the Yin-Yang interplay between inflammation and cancer. Oncogene. 2010;29(23):3313–23. doi:10.1038/onc.2010.109
   PubMed Web of Science ®Google Scholar
• Pousa ID, Mate J, Gisbert JP. Angiogenesis in inflammatory bowel disease. Eur J Clin Invest. 2008;38(2):73–81. doi:10.1111/j.1365-2362.2007.01914.x
   PubMed Web of Science ®Google Scholar
• Alkim C, Alkim H, Koksal AR, Boga S, Sen I. Angiogenesis in inflammatory bowel disease. Int J Inflam. 2015;2015:970890. doi:10.1155/2015/970890
   PubMed Web of Science ®Google Scholar
• Scaldaferri F, Vetrano S, Sans M, Arena V, Straface G, Stigliano E, Repici A, Sturm A, Malesci A, Panes J, et al. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis. Gastroenterology. 2009;136(2):585–95 e5. doi:10.1053/j.gastro.2008.09.064
   PubMed Web of Science ®Google Scholar
• Zhu G, Huang Q, Zheng W, Huang Y, Hua J, Yang S, Zhuang J, Wang J, Chang J, Xu J, et al. LPS Upregulated VEGFR-3 expression promote migration and invasion in colorectal cancer via a mechanism of increased NF-κB binding to the promoter of VEGFR-3. Cell Physiol Biochem. 2016;39(5):1665–78. doi:10.1159/000447868
   PubMedGoogle Scholar
• Li Y, Zhu H, Wei X, Li H, Yu Z, Zhang H, Liu W. LPS induces HUVEC angiogenesis in vitro through miR-146a-mediated TGF-beta1 inhibition. Am J Transl Res. 2017;9(2):591–600.
   PubMed Web of Science ®Google Scholar